|
HROW
|
Harrow Health, Inc.
|
0.04%
|
US
|
NASDAQ
|
|
FATE
|
Fate Therapeutics, Inc.
|
0.04%
|
US
|
NASDAQ
|
|
ESPR
|
Esperion Therapeutics, Inc.
|
0.04%
|
US
|
NASDAQ
|
|
EOLS
|
Evolus, Inc.
|
0.04%
|
US
|
NASDAQ
|
|
EGRX
|
Eagle Pharmaceuticals, Inc.
|
0.04%
|
US
|
NASDAQ
|
|
CRBU
|
Caribou Biosciences, Inc.
|
0.04%
|
US
|
NASDAQ
|
|
AVDL
|
Avadel Pharmaceuticals plc
|
0.04%
|
US
|
NASDAQ
|
|
ARCT
|
Arcturus Therapeutics Ltd.
|
0.04%
|
US
|
NASDAQ
|
|
ALXO
|
ALX Oncology Holdings Inc.
|
0.04%
|
US
|
NASDAQ
|
|
NGM
|
NGM Biopharmaceuticals, Inc.
|
0.04%
|
US
|
NASDAQ
|
|
KZR
|
Kezar Life Sciences, Inc.
|
0.04%
|
US
|
NASDAQ
|
|
KOD
|
Kodiak Sciences Inc
|
0.04%
|
US
|
NASDAQ
|
|
TERN
|
Terns Pharmaceuticals, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
STOK
|
Stoke Therapeutics, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
PGEN
|
Precigen, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
PETQ
|
PetIQ, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
PAHC
|
Phibro Animal Health Corporation
|
0.03%
|
US
|
NASDAQ
|
|
OCUL
|
Ocular Therapeutix, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
NSTG
|
NanoString Technologies, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
MGTX
|
MeiraGTx Holdings plc
|
0.03%
|
US
|
NASDAQ
|